Company Announcements

Consent to Migration

Source: RNS
RNS Number : 2405Q
Smurfit Kappa Group PLC
24 February 2021



24 February 2021



Regulatory Announcement


Smurfit Kappa Group plc


("Smurfit Kappa" or the "Company")


Smurfit Kappa Consents to the Migration of its Ordinary Shares


As previously announced, the shareholders of the Company approved resolutions in relation to the replacement of the CREST system with a system operated by Euroclear Bank SA/NV for the electronic settlement of trading in the Company's ordinary shares at the extraordinary general meeting held on 5 February 2021 (the "EGM").  The full text of each resolution was set out in the Notice of EGM which was contained in the circular made available to shareholders on the Company's website at


In accordance with Resolution 1 approved at the EGM, on 19 February 2021 the Company consented to the migration of its ordinary shares to the Euroclear Bank SA/NV central securities depository in accordance with the Migration of Participating Securities Act 2019.  The requisite notifications in connection with the migration have also been made by the Company to the Irish Companies Registration Office and Euronext Dublin.


The migration of the Company's ordinary shares will take place as part of the wider market migration of the shares of the listed Irish companies which have consented to the migration. The market migration will take place on the date determined by Euronext Dublin, which is currently expected to be on or around 15 March 2021.  Further announcements will be made in relation to the migration

timetable in due course.


Any relevant updates regarding the migration will be announced via a Regulatory Information Service and will be available on


For further information on the announcement, please contact:


Group Secretary

Gillian Carson-Callan

T: +353 1 202 7152







This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.